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Background: Altered plasma lipids, oxidative stress, and inflammation have been involved in the pathogenesis of
cardiovascular disease. Fish oil has shown inconclusive effects on plasma lipids and oxidative stress. Spirulina
has both cholesterol lowering and antioxidant properties. However, the effect of fish oil and spirulina on
hypercholesterolemia has not been studied. We investigated the effects of fish oil, spirulina, and their
combination on hypercholesterolemia.
Methods: The hamsters were divided into 7 groups: control, high cholesterol (HF), fish oil (post FO), spirulina
(post SP), and a combination of fish oil and spirulina (post SF, pre-SF, and HF + SF) groups. The HF and HF + SF
groups were given a high cholesterol diet for 8 weeks. The post FO, post SP, and post SF groups were given a high
cholesterol diet for 4 weeks and then the treatment for 4 weeks. The pre-SF group was given the combined treatment
for 4 weeks and then a high cholesterol diet for 4 weeks.
Results: The HF and HF + SF groups altered plasma lipids, increased oxidative stress, inhibited antioxidants, and
increased inflammation. While the post FO group increased plasma lipids and was more atherogenic. The vice versa
was observed in spirulina-treated group. Both the post SP and post SF groups inhibited oxidative stress and increased
antioxidant status, and post FO and post SP diets regulated pro-inflammatory cytokines to near the control levels.
Conclusions: Both single treatment of fish oil or spirulina inhibit oxidative stress and inflammation. Treatment with a
combination of fish oil and spirulina (post SF) may be beneficial for diet-induced hypercholesterolemic hamsters.
Keywords: Hypercholesterolemia, Spirulina, Fish oil, Oxidative stress, InflammationBackground
Cardiovascular disease (CVD) is the most common cause
of mortality and morbidity in the West, accounting for
more than 50% of all deaths [1]. Hypercholesterolemia on
the other hand has been identified as a critical step in the
development of atherosclerosis and a predisposing risk
factor for CVD [2]. Various studies have shown a positive
correlation between cholesterol levels and the risk of
hypercholesterolemia and hence characterizing it by ele-
vated levels of LDL-C and total cholesterol and low level
of HDL-C [2-6]. Furthermore, the elevated cholesterol* Correspondence: chenjui@tmu.edu.tw
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article, unless otherwise stated.levels sets stage for the formation of free oxygen radicals
hence increasing oxidative stress and suppressing the anti-
oxidant enzymes. Both clinical and animal studies have
shown increased lipid peroxidation in plasma and a poor
antioxidant defense system in the presence of hyperchol-
esterolemia [7-9].
Some of the dietary management methods for CVD
include the use of fish oil and positive effects in human
studies and in other animal models have been observed
[10-15]. However, in hamsters it has shown opposite re-
sults by increasing their lipid profiles in the presence of a
high cholesterol diet; an effect that is attributed to the de-
crease in hepatic LDL-receptor mRNA expression [16-18].
Furthermore, both animal and human studies show con-
flicting results on the ability of fish oil to prevent forma-
tion of free radicals and to improve the antioxidant statustral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Compositions of the standard and
hypercholesterolemic diets





Corn starch 470.35 470.35
Alphacel 50.50 50.50
Soybean oil 40.40 40.40
L-cystine 1.82 1.82
Choline bitartrate 2.53 2.53
Tert-butylhydroquinone 0.0081 0.0081
Sucrose 101.00 101.00
Dextrinized cornstarch 156.55 156.55
Mineral/vitamin mix 35.45 35.45
Cholesterol 0.00 0.0126
Cocoa butter 0.00 0.076
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oil with its high peroxidation ability can still lower blood
lipids and exhibit antioxidant properties. Nevertheless, in-
vitro studies have shown that fish oil can regulate inflam-
mation by inhibiting the production of pro-inflammatory
cytokines and adhesion molecules related to athero-
sclerosis [25,26].
On the other hand, antioxidant vitamin is beneficial for
cardiovascular patients because of their ability to inhibit
oxidation or the uptake of LDL cholesterol [27]. However,
the effects of antioxidants on cardiovascular health have
shown conflicting results [28]. The most common form
of antioxidant used with fish oil is vitamin E because
of its anti-atherogenic ability to inhibit LDL oxidation
[9,29,30]. However, the evidence suggests that fish oil
greatly lowers plasma vitamin E level in hypercholes-
terolemic subjects. The recent animal study observed
the effect of stress on the antioxidant status of ani-
mals and found that stress increased the level of lipid
peroxides and reduced the levels of antioxidants (vita-
min E and L-ascorbic acid) in liver and kidney [31].
The previous studies showed that fish oil combined
with vitamin E significantly reduced the concentration
of vitamin E in the body [32,33]. However, few studies
have demonstrated the effects of water-soluble antioxi-
dants combined with fish oil on hypercholesterolemia.
Spirulina, a green-blue algae, was used in this study,
because it had cholesterol-lowering ability, protected
against free radicals and cell death, and increased antioxi-
dant enzyme activities in both plasma and liver [34-37].
However, the effects of spirulina on inflammatory cyto-
kines in hypercholesterolimic and atherogenic conditions
have not been elucidated.
The objective of this study was to compare the effects of
single treatment of fish oil or spirulina and their combin-
ation on plasma lipids, oxidative stress, and inflammation




Male Golden Syrian hamsters (n = 84) were obtained
from National laboratory Animal Center (Taiwan). The
hamsters were 8-week old at the time of their delivery.
The animals were fed on a commercial rodent chow diet
for 3 days to be acclimated to the facility before the com-
mencement of the experiment. Hamsters were housed in
stainless steel and wired-bottomed hanging cages in an
environmentally controlled atmosphere (23°C) on a 12-h
light:dark cycle. Hamsters consumed their feed and water
ad libitum before and during the experimental period. All
animal protocols were approved and in accordance with
the guidelines of the Institutional Animal Care and Use
Committee of Taipei Medical University.Diets and treatments
On the third day after delivery of the hamsters to the insti-
tution, their diet was switched from the standard rodent
chow to AIN-93 M diet for 7 days. The AIN-93 M diet
has a balance of essential nutrients and is suitable for both
long- and short-term studies with laboratory rodents.
While the control group (C) was given the AIN-93 M diet,
all other experimental diets were modified from the basic
AIN-93 M diet. The high cholesterol diet (HF) was pre-
pared by adding 7.5% cocoa butter and 1.25% cholesterol
to the AIN-93 M diet (Table 1) [38]. In addition, 0.08 g/kg
feed of fish oil from menhaden fish (Sigma-Aldrich China,
Inc., Shanghai, China) and 0.011 g/kg feed of spirulina
(Fuqing King Dnarmsa Spirulina Co., Ltd, FuQing, China)
were subsequently added by small amounts with continu-
ous stirring to the AIN-93 M diet to constitute the fish oil
(FO) and spirulina (SP) diets, respectively. The same doses
of fish oil and spirulina were added together to either the
AIN-93 M or to the HF diet to form the diets for com-
bined treatments (SF and HF + SF). Fatty acid composi-
tions in menhaden fish oil (Sigma-Aldrich China) are
composed of approximately 80% identified fatty acids,
including 6-9% myristic acid (14:0), 15-20% palmitic
acid (16:0), 9-14% palmitoleic acid (16:1), 3-4% stearic
acid (18:0), 5-12% oleic acid (18:1), < 3% linoleic acid
(18:2), < 3% linolenic acid (18:3), 2-4% octadecatetraenoic
acid (18:4), < 3% arachidonic acid (20:4), 10-15% eicosa-
pentaenoic acid (EPA, 20:5), and 8-15% docosahexaenoic
acid (DHA, 22:6), and 20% unidentified fatty acids. Spiru-
lina powder (Fuqing King Dnarmsa Spirulina Co., Ltd)
primarily contains 65.2% protein, 6.6% water, 6.7% ash,
13.7% crude ohycocyanin, 1241 mg/100 g chlorophyll, and
463 mg/100 g total carotenoids.
After the acclimatization period, hamsters were ran-
domly divided into 7 groups and housed in groups of 4 per
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received a high cholesterol diet with either fish oil, spiru-
lina, or a combination of fish oil and spirulina as follows:
control (C, n = 12), high cholesterol (HF, n = 12), fish oil
(post FO, n = 12), spirulina (post SP, n = 12), spirulina
and fish oil (post SF, n = 12), treatment then the in-
duction of hypercholesterolemia (pre-SF, n = 12), and the
induction of hypercholesterolemia + treatment (HF + SF,
n = 12) groups. The post FO, post SP, and post SF groups
were first fed a high cholesterol diet to induce hyper-
cholesterolemia for 4 weeks followed by different treat-
ments for the remaining 4 weeks. The pre-SF group was
first fed a combination of spirulina and fish oil for 4 weeks
and then a high cholesterol diet for the last 4 weeks.
The comparisons between the high cholesterol diet
and control groups were to determine whether the in-
duction of hypercholesterolemia was successful by pri-
marily measuring plasma lipid levels. Additionally, since
the hamsters had different treatments with different feed-
ing periods, all treatment groups were compared with
the control group which served as the baseline for
the values of the dependent variables to determine
whether the treatments had significant effects compared
with the control hamsters with normal dependent vari-
ables. The HF + SF group was compared with the HF
group because both groups were given a high cholesterol
diet for 8 weeks with or without treatment, respect-
ively, and the post FO, post SP, post SF, and pre-SF
groups were compared with each other to study the pre-
and post-treatment effects of fish oil and/or spirulina.
Body weight of the hamsters was recorded weekly
and at the 8th week of the study period. Blood, liver,
and aorta samples were collected from food-deprived
(16 h) hamsters for plasma lipids, aortic cholesterol
concentration, TNF-α, IL-1β, and IL-10 in the aorta,
antioxidants (total glutathione, GSH; glutathione per-
oxidase, GSHPx; superoxide dismutase, SOD), and lipid
peroxidation (thiobarbituric acid reactive substances,
TBARS) in liver.
Measurements of plasma lipids
Blood was drawn in heparinized tubes by heart punctu-
ation and placed on ice. The collected blood was then
centrifuged at 1500× g at 4°C for 10 min. Plasma super-
natant was used for the determination of total cholesterol
(TC), triglycerides (TG), and high density lipoprotein-
cholesterol (HDL-C) using enzymatic kits purchased from
Randox Laboratories (Antrim, Northern Ireland, UK).
Low density lipoprotein-cholesterol (LDL-C) was calcu-
lated as the difference between plasma TC and HDL-C.
The ratio of plasma TC to HDL-C was then calculated,
and the atherogenic index of plasma (AIP) was deter-
mined as Log (TG/HDL-C) for the risk of cardiovascular
disease [39].Aortic cholesterol levels
At the end of the exposure period (week 8), hamsters
were anesthetized with intraperitoneal injection of so-
dium pento-barbital, and aortic tissue was obtained for
the determination of cholesterol and cytokine concentra-
tions. A section of aortic tissue (20–40 mg) extended from
as close to the heart as possible to the branch of the left
subclavian artery was dissected, minced, and homogenized
in phosphate-buffered saline (pH 7.0). The homogenized
tissue was centrifuged at 400× g for 10 min. The super-
natant was collected and stored at −20°C.
Aortic lipids were extracted according to the modi-
fied method of Alexaki et al. [40]. Methanol (4 ml) and
chloroform (8 ml) were separately added to aortic hom-
ogenate. The solution (3 ml) containing 1.25% KCl and
0.05% H2SO4 was then added and centrifuged at 400× g
at room temperature for 10 min. The bottom layer was
transferred and the supernatant was re-extracted with
3 ml of chloroform:methanol (2:1) and centrifuged at
400× g at room temperature for 10 min. The bottom
layer was transferred and pooled with that from the previ-
ous step. The chloroform solution was stored at −20°C
until analysis.
After chloroform was completely evaporated, chloro-
form (1 ml) with 1% Triton-100 was added, mixed, and
completely evaporated. Distilled water (500 μl) was then
added, and the sample was placed in a shaking water
bath at 37°C for 20 min to solubilize lipids. After incu-
bation, aortic total cholesterol concentration was de-
termined enzymatically using commercial kits (Randox
Laboratories).Hepatic lipid peroxidation
Liver sample (0.3 g) was homogenized in 1.2 ml of 50 mM
Tris–HCl. The homogenate was then centrifuged at
8500× g at 4°C for 10 min, and the supernatant was used
for biochemical analysis. Protein concentration in each
fraction was determined by the method of Lowry et al.
[41]. The mean thiobarbituric acid reactive substances
(TBARS) (μmol/mg protein), a measure of lipid peroxida-
tion, was assayed in the form of malondialdehyde (MDA)
using a commercial kit purchased from Cayman Chemical
Company (Ann Arbor, MI, USA).Liver glutathione (GSH) level and glutathione peroxidase
(GSHPx) activity
Liver samples (0.3 g) were homogenized in 5% meta-
phosphoric acid (pH 7.0). The homogenate was then
centrifuged at 3000× g for 10 min, and the supernatant
was used for biochemical analysis. Protein concentration
in each fraction was determined by the method of Lowry
et al. [41]. Glutathione level was assayed using a com-
mercial kit purchased from Cayman Chemical Company,
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kit purchased from Randox Laboratories.
Liver superoxide dismutase (SOD) activity
Liver samples (0.3 g) for the determination of SOD ac-
tivity were homogenized in a solution containing 0.25 M
sucrose, 50 mM Tris HCl, and 5 mM EDTA (pH 7.0).
The homogenate was then centrifuged at 8500× g at 4°C
for 10 min, and the supernatant was used for biochem-
ical analysis. Liver SOD activity was expressed as activity
per mg protein. Protein concentration in each fraction
was determined by the method of Lowry et al. [41]. The
activity of superoxide dismutase was assayed using a
commercial kit purchased from Randox Laboratories.
Aortic TNF-α, IL-1β, and IL-10 levels
The proinflammatory (TNF-α and IL-1β) and anti-
inflammatory (IL-10) cytokines were measured using
commercial kits (Shangai BlueGene Biotech Co., Shanghai,
China). Standards or samples (50 μl) were added in the
antibody pre-coated plate followed by 100 μl of conjugate
solution and incubated for 1 h at 37°C. Reactive substrates
were added for 10 min at 20-25°C, and the optical density
was read at 450 nm using an ELISA microplate reader.
Statistical analysis
The data are expressed as mean ± SD. One-way analysis
of variance (ANOVA) and Fisher’s least significant differ-
ence test were used for the differences in means using
Statistical Analysis System (SAS version 9.3, SAS Institute
Inc., Cary, NC, USA). P-value < 0.05 was considered statis-
tically significant.
Results
General characteristics of the hamsters
Body weights were not significantly different at week 0
among different groups, and not significantly different
among the control, HF, post FO, post SP, and post SF
groups throughout the experimental period (Table 2).
While the HF+ SF group had lower body weights com-
pared with the control group throughout the experimen-
tal period (p < 0.05), the pre-SF group had higher body
weights compared with all post-treatment groups at week
4 (p < 0.05). However, despite the positive increase in body
weight in all groups at week 8, the HF + SF group still had
significantly lower body weight and weight gain compared
with the control group (p < 0.05). Average food intake was
decreased in the post FO, post SF, pre-SF, and HF + SF
groups compared with the control and HF groups
(p < 0.05). Reduced food intake in all fish oil groups may
be attributed to the increased satiety by fat content in fish
oil diet and the strong flavor of fish oil. The reduction in
food intake may partially explain lower body weight and
weight gain in the HF + SF group. While food efficiency inthe HF and HF + SF groups was lower compared with the
control group (p < 0.05), and that in the post SF and pre-
SF groups was lower compared with the control and post
SP groups. The post SP group restored food efficiency to
the similar level as the control group. The induction of
hypercholesterolemia at the beginning of the experiment
had a significant effect on liver weight. All experimental
groups had an increase in liver wet weight when com-
pared with the control group (p < 0.05). However, the post
FO, post SP, and post SF groups had significantly lower
liver weights compared with the pre-SF group (p < 0.05).
On the other hand, the relative liver weights of all ex-
perimental groups were significantly higher than the
control group, and the post SP group had significantly
lower relative liver weights than the post SF and pre-SF
groups (p < 0.05). Aorta wet weight was not different in all
experimental groups compared with the control group.
While the HF, HF + SF, post FO, and post SF groups had
increased relative aorta weight compared with the control
group (p < 0.05), there were no differences in relative aor-
tic weight among the post SP, pre-SF, and the control
groups (p < 0.05).
Effect of treatments on plasma and aortic lipids
Hypercholesterolemia alters the lipid profile of the ham-
sters. The HF group had significantly higher plasma TC,
HDL-C and LDL-C levels, as well as elevated athero-
genic index and aortic TC level compared with the con-
trol group (p < 0.05) (Table 3). Plasma TC level of the
hamsters in all groups was significantly different from
the control group (p < 0.05). The post SP group had the
lowest plasma TC levels among the groups induced with
hypercholesterolemia for 4 weeks, and the HF + SF group
had the highest plasma TC levels compared with the con-
trol and HF groups (p < 0.05). The addition of fish oil
could not lower plasma TC levels and hence the post FO,
post SF, and pre-SF groups had similar plasma TC levels.
A similar trend was observed with plasma LDL-C levels;
the higher plasma TC levels, the greater plasma LDL-C
levels and vice versa. The post SF group had the highest
plasma TG levels among the pre- and post-treatment
groups (p < 0.05). Plasma TG levels in the HF + SF group
were higher than those in the HF and control groups
(p < 0.05). Plasma TG levels in the HF, post FO, post
SP, and pre-SF groups did not differ significantly from
the control group. Plasma HDL-C levels were higher in
the HF, post SP, pre-SF, and HF + SF groups compared
with those in the control group (p < 0.05), and lower in
the post FO and post SF compared with those in the
post SP and pre-SF groups (p < 0.05). The post SP group
had the highest plasma HDL-C levels among other post-
and pre-treatment groups. The HF + SF group had de-
creased plasma HDL-C levels compared with the HF
group (p < 0.05). Plasma HDL-C levels in the post FO
Table 2 Body, liver, and aorta weights of hamsters in different groups
Control HF Post FO Post SP Post SF Pre-SF HF + SF
Body weight, g
Week 0 110.2 ± 3.3a 112.6 ± 8.5a 112.0 ± 12.3a 111.7 ± 9.5a 112.2 ± 9.3a 112.6 ± 7.8a 110.5 ± 11.1a
Week 4 120.1 ± 11.0b 113.9 ± 10.0ab 112.3 ± 11.6ab 114.2 ± 11.7ab 113.5 ± 12.6ab 129.7 ± 10.0c 110.1 ± 8.6a
Week 8 134.3 ± 14.6b 117.4 ± 10.5ab 119.0 ± 12.6ab 125.2 ± 8.9b 118.1 ± 12.0ab 132.5 ± 10.1b 110.9 ± 8.8a
Change in body weight, g 14.2 ± 5.7c 3.5 ± 8.5ab 6.7 ± 4.2b 10.9 ± 7.2bc 4.7 ± 6.9ab 2.9 ± 6.7ab 0.8 ± 2.8a
Food intake, g/day 7.6 ± 0.1d 7.5 ± 0.3d 6.9 ± 0.1b 7.5 ± 0.1d 6.6 ± 0.3b 7.2 ± 0.2c 5.8 ± 0.6a
Food efficiency, % 7.6 ± 3.3c 0.5 ± 1.3ab 3.6 ± 2.3bc 5.4 ± 3.6c 2.6 ± 3.9b 1.5 ± 3.4ab 0.5 ± 1.9a
Liver wet weight, g 4.3 ± 0.7a 7.3 ± 0.8c 6.1 ± 0.7b 6.0 ± 0.9b 6.2 ± 0.8b 7.1 ± 0.8c 6.8 ± 0.6c
Relative liver weight, % 3.2 ± 0.3a 6.4 ± 0.7d 5.1 ± 0.3bc 4.8 ± 0.5b 5.3 ± 0.5c 5.4 ± 0.3c 6.1 ± 0.5d
Aorta wet weight, mg 33.0 ± 1.4ab 34.3 ± 2.1b 32.4 ± 4.3a 32.6 ± 1.6ab 33.5 ± 1.5a 32.4 ± 1.3a 34.1 ± 1.4b
Relative aorta weight, % 0.02 ± 0.001a 0.03 ± 0.003bc 0.03 ± 0.003b 0.03 ± 0.003ab 0.03 ± 0.003b 0.02 ± 0.002a 0.03 ± 0.003c
Data are presented as mean ± SD (n = 12/group). Values in a row not sharing the same superscript letter are significantly different at p < 0.05. HF: high fat diet +
cholesterol; post FO: fish oil diet after induction with HF diet; post SP: spirulina diet after induction with HF diet; Post SF: spirulina and fish oil diet after induction
with HF diet; Pre-SF: pre-treatment with spirulina and fish oil diet before induction with HF diet; HF + SF: HF diet combined with spirulina and fish oil.
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control group. The ratio of TC to HDL-C was signifi-
cantly lower in the post SP group, but significantly higher
in the post FO group compared with other post- and pre-
treatment groups (p < 0.05). The HF + SF group had in-
creased the ratio of TC to HDL-C compared with the HF
group (p < 0.05). The atherogenic index of plasma was sig-
nificantly higher in the HF group compared with that in
the control and HF + SF groups (p < 0.05), and was signifi-
cantly lower in the post SP group compared with that
in the control, post FO, post SF, and pre-SF groups
(p < 0.05). This finding suggests that a high cholesterol
diet is more atherogenic, while the spirulina diet (post SP)
and pre-SF treatment is less atherogenic. The findings of
aortic lipid concentration showed that the HF group had
the highest accumulation of TC in the aorta compared
with the control and HF + SF groups (p < 0.05).
Effect of treatments on hepatic lipid peroxidation and
antioxidant status
We determined the effectiveness of the treatments on
protecting against lipid peroxidation and improving theTable 3 Treatment effects on plasma and aortic lipids in the h
Control HF Post FO
TC, mmol/l 7.2 ± 1.3a 23.1 ± 6.7c 28.7 ± 3.0
TG, mmol/l 5.5 ± 1.6ab 6.6 ± 0.9ab 7.4 ± 1.2b
HDL-C, mmol/l 3.6 ± 1.1a 7.2 ± 3.1cd 3.6 ± 0.6a
LDL-C, mmol/l 2.9 ± 1.8a 14.5 ± 5.9b 23.6 ± 3.0
TC/HDL-C 2.1 ± 0.8a 5.1 ± 6.1bc 8.0 ± 1.6d
AIP, Log (TG/HDL-C) 0.16 ± 0.05b 0.43 ± 0.16d 0.30 ± 0.1
Aortic TC, nmol/mg aorta 1.0 ± 0.5a 9.9 ± 20.9b 4.6 ± 4.2a
Data are presented as mean ± SD (n = 12/group). Values in a row not sharing the sa
cholesterol; post FO: fish oil diet after induction with HF diet; post SP: spirulina diet
with HF diet; Pre-SF: pre-treatment with spirulina and fish oil diet before induction
cholesterol; TG: Triglycerides; HDL-C: High density lipoprotein-cholesterol; LDL-C: Loantioxidant defense system in the presence of hyperchol-
esterolemia. A high cholesterol diet increased the level
of lipid peroxidation in the liver above control levels
(1.5 ± 0.3 vs 0.7 ± 0.2 μmol/mg protein, p < 0.05) (Figure 1).
While both single and combined treatments of spirulina
and fish oil reduced lipid peroxidation level to near or
below control levels, the post SF group had the greatest
reduction in hepatic lipid peroxides (post FO, 0.7 ± 0.1,
pre-SF, 0.7 ± 0.1, and post SF, 0.4 ± 0.1 μmol/mg protein,
p < 0.05). This finding suggests that single or combined
use of spirulina and fish oil may prevent or treat lipid per-
oxidation. To further understand the protective effect of
the treatments in this study, several antioxidant enzymes
in the liver were analyzed. Hepatic GSH level was de-
creased in the HF group compared with that in the con-
trol group, but not different from the HF + SF group
(Figure 2A). The post SF group had the highest GSH level
(3.4 ± 0.5 μmol/mg protein, p < 0.05) compared with the
post FO, post SP, and pre-SF groups except the control
group (Figure 2A). The use of spirulina as a single treat-
ment or in combination with fish oil increased GSHPx
activity compared with other post-treatment groups andamsters
Post SP Post SF Pre-SF HF + SF
d 15.5 ± 1.4b 28.6 ± 4.8d 27.1 ± 7.4cd 48.1 ± 6.7e
7.9 ± 2.7b 9.7 ± 2.0c 7.5 ± 2.2b 10.3 ± 2.7c
7.5 ± 1.1d 4.3 ± 0.6ab 6.1 ± 1.5c 5.0 ± 1.1b
c 6.4 ± 1.2a 22.4 ± 4.5c 19.5 ± 7.3c 41.0 ± 6.4d
2.1 ± 0.3a 6.8 ± 1.3c 4.7 ± 1.8b 10.1 ± 2.6d
2c 0.12 ± 0.06a 0.28 ± 0.04c 0.14 ± 0.12b 0.31 ± 0.15c
b 2.0 ± 1.3a 1.3 ± 0.9a 2.0 ± 1.7a 2.1 ± 1.7a
me superscript letter are significantly different at p < 0.05. HF: high fat diet +
after induction with HF diet; Post SF: spirulina and fish oil diet after induction
with HF diet; HF + SF: HF diet combined with spirulina and fish oil. TC: Total
w-density lipoprotein-cholesterol; AIP: atherogenic index of plasma.
Figure 1 Effect of fish oil, spirulina, and their combination on
lipid peroxidation expressed as thiobarbituric acid reactive
substances (TBARS) in liver. Data are presented as mean ± SD
(n = 12/group). Values not sharing the same letter are significantly
different at p < 0.05. HF: high fat diet + cholesterol; post FO: fish
oil diet after induction with HF diet; post SP: spirulina diet after
induction with HF diet; Post SF: spirulina and fish oil diet after
induction with HF diet; Pre-SF: pre-treatment with spirulina and
fish oil diet before induction with HF diet; HF + SF: HF diet combined
with spirulina and fish oil.
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9.7, and post SF, 25.0 ± 6.3 unit/mg protein, p < 0.05)
(Figure 2B). The activity of SOD was lower in the HF
group compared with the control, but did not differ from
the HF + SF group (0.4 ± 0.2, 1.7 ± 0.7, and 0.7 ± 0.3 unit/
mg protein, respectively, p < 0.05). However, hepatic SOD
activity in the control, post FO, post SP, post SF, and pre-SFFigure 2 Effect of fish oil, spirulina, and their combination on (A) GSH
presented as mean ± SD (n = 12/group). Values not sharing the same letter ar
fish oil diet after induction with HF diet; post SP: spirulina diet after induction
diet; Pre-SF: pre-treatment with spirulina and fish oil diet before induction wit
glutathione; GSHPx: glutathione peroxidase; SOD: superoxide dismutase.(1.7 ± 0.7, 1.3 ± 0.8, 1.8 ± 1.3, 1.8 ± 0.8, and 0.8 ± 0.6 unit/
mg protein) groups did not differ significantly (Figure 2C).
Effect of treatments on aortic inflammation
Hypercholesterolemia and inflammation are key pro-
cesses in the pathogenesis of atherosclerosis. In this
study, both pro- and anti-inflammatory cytokines in the
aorta were investigated. The HF group increased pro-
inflammatory cytokines, TNF-α and IL-1β, in the aorta
compared with the control group (p < 0.05) (Table 4).
Aortic TNF-α concentrations were higher in the post
FO, post SF, pre-SF, and HF + SF groups compared with
those in the control group, and also increased in the
pre-SF group compared with those in the post FO,
post SP, and post SF groups. While IL-1β concentra-
tions in the aorta were increased in the post SF, pre-SF,
and HF + SF groups compared with those in the control
group (p < 0.05), aortic IL-1β concentrations did not differ
significantly in the control, post FO, and post SP groups.
On the contrary, the post FO, post SP, post SF, and pre-SF
groups elevated aortic level of anti-inflammation cytokine
(IL-10) compared with the control group (p < 0.05). How-
ever, aortic TNF-α, IL-1β, and IL-10 levels were not differ-
ent between the HF and HF + SF groups.
Discussion
The severity of hypercholesterolemia, the pathogenesis
of atherosclerosis, and CVD risk warrant the need toconcentration, (B) GSHPx, and (C) SOD activities in liver. Data are
e significantly different at p < 0.05. HF: high fat diet + cholesterol; post FO:
with HF diet; Post SF: spirulina and fish oil diet after induction with HF
h HF diet; HF + SF: HF diet combined with spirulina and fish oil. GSH:
Table 4 Treatment effects on aortic cytokine concentrations
Control HF Post FO Post SP Post SF Pre-SF HF + SF
TNF-α, pg/mg aorta 10.0 ± 1.2a 13.8 ± 2.3c 11.5 ± 0.7b 11.2 ± 0.5ab 11.8 ± 1.2b 12.8 ± 1.2c 12.8 ± 1.5c
IL-1β, pg/mg aorta 3.9 ± 0.7a 5.7 ± 10.0c 4.6 ± 0.5ab 4.5 ± 0.4ab 4.8 ± 0.5b 4.8 ± 0.4b 5.2 ± 1.3bc
IL-10, pg/mg aorta 7.6 ± 7.0a 8.1 ± 3.4a 15.6 ± 4.2bc 19.4 ± 6.7c 16.4 ± 4.4c 12.8 ± 3.8b 7.4 ± 10.0a
Data are presented as mean ± SD (n = 12/group). Values in a row not sharing the same superscript letter are significantly different at p < 0.05. HF: high fat diet +
cholesterol; post FO: fish oil diet after induction with HF diet; post SP: spirulina diet after induction with HF diet; Post SF: spirulina and fish oil diet after induction
with HF diet; Pre-SF: pre-treatment with spirulina and fish oil diet before induction with HF diet; HF + SF: HF diet combined with spirulina and fish oil. TNF-α: tumor
necrosis factor- α, IL-1β: interleukin-1 β, IL-10: interleukin-10.
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Hypercholesterolemia, characterized by altered plasma
lipids and increased oxidative stress and inflammation, re-
quires both cholesterol-lowering and antioxidant therap-
ies, which were beneficial to patients with atherosclerosis
by improving endothelium-dependent vasomotion [42].
Since limited studies have observed the effect of fish
oil and spirulina, this study determined the effects of fish
oil, spirulina, and their combination on hypercholesterol-
emia. It was hypothesized that there would be differential
effects between fish oil and spirulina, but a combination
would be more effective.
The HF + SF group had lower body weight at week 8
compared with the control group, but similar body weight
compared with the HF group despite that increased
plasma cholesterol and TG levels were observed in the
HF + SF group. Decreased body weight and weight gain in
the HF + SF group could be attributed to lower food in-
take and food efficiency, while higher levels of plasma
cholesterol and TG could be as a result of lipid synthesis
and metabolism. Since the HF + SF group was given a high
cholesterol diet supplemented with fish oil, it is possible
that high levels of plasma lipids could be as a result of de
novo (from the liver) and exo synthesis (from the diet).
Our results showed that the tendency that the control
and pre-SF groups with higher body weight at week 8
had decreased relative aorta weight, which could be
because pre-treatment with spirulina and fish oil effect-
ively decreased the increased relative aorta weight caused
by a high cholesterol diet to the similar value as the
control group. However, it cannot rule out that the vari-
ation for aorta wet weight might be affected by a small
deviation during the removal of the aorta manually. A
high cholesterol diet generally increased all plasma
lipids, and was atherogenic because cholesterol was ac-
cumulated in the aorta. Elevated plasma lipids have been
associated with adverse cardiovascular outcomes. High
total cholesterol level has been shown to alter vascular
structure and interfere with endothelial function, while
TG and LDL-C levels have been directly linked to poor
cardiovascular outcomes [2,4-6].
In hamsters, fish oil-induced hypercholesterolemia and
hyperlipidemia has been shown to be dependent on diet-
ary cholesterol supplementation. The previous studiesfound that the hamsters fed a high cholesterol diet sup-
plemented with fish oil affected plasma TC and LDL-C
levels, but not HDL-C particle [16-18]. Similar to the find-
ings of the previous studies, the present study observed
that the post FO diet greatly increased plasma TC and
LDL-C levels, but did not increase plasma HDL-C levels.
Our results also showed that the HF + SF group increased
plasma TC, TG, and LDL-C levels but decreased plasma
HDL-C levels compared with the HF group. The adverse
effect of the HF + SF diet may be primarily attributed to
fish oil rather than spirulina. The possible mechanism for
increasing plasma LDL-C levels by fish oil in hamsters
may be partially due to decreased hepatic LDL-receptor
binding which was dependent on the dietary cholesterol
content [18]. In addition, supplementation with fish oil
was also found to increase TC:HDL-C ratio even though it
did not elevate cholesterol accumulation in the aorta. This
particular finding contradicts the findings from the previ-
ous studies that have shown the anti-atherogenic effect
of fish oil supplementation for a longer period of time
[12,13,43]. However, fish oil treatment for 2 years lowered
plasma TG levels, but did not change the diameter of ath-
erosclerotic coronary arteries in the patients with coronary
heart disease [44].
On the other hand, a high cholesterol diet with spiru-
lina decreased TC and LDL-C while increasing HDL-C.
This observation is in accordance with the previous
studies that demonstrated cholesterol-lowering ability of
spirulina regardless of the method used to induce hyper-
cholesterolemia and hyperlipidemia [45-47]. Moreover,
the spirulina diet was found to be less atherogenic and
hence inhibited cholesterol accumulation in the aorta.
The results showed that spirulina can protect against the
development of atherosclerosis by lowering blood chol-
esterol levels [46].
A combination of spirulina and fish oil led to differen-
tial results that rejected the hypothesis with regard to
lowering cholesterol levels. There was an increment in
cholesterol levels when spirulina and fish oil were com-
bined as shown in the post SF, pre-SF, and HF + SF
groups. These findings, however, could be attributed to
the effect of fish oil which did not lower plasma lipids.
Never the less, it would be interesting to note that re-
gardless of elevated cholesterol levels, all combinations
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pre-SF treatment exhibited lower TC:HDL-C ratio and
AIP level. The results suggest that pre-treatment with
combined spirulina and fish oil can prevent against ath-
erosclerosis by inhibiting cholesterol accumulation in
the aorta.
A number of human and animal studies have demon-
strated an increase in oxidative stress in the presence of
hypercholesterolemia. In these studies, the induction of
hypercholesterolemia increased lipid peroxidation in tis-
sues and serum while reducing the antioxidant enzymes
such as GSHPx and SOD activities [7-9,37]. Likewise in
this study, hypercholesterolemia increased lipid peroxi-
dation, and decreased hepatic GSH level, GSHPx, and
SOD activities in hamsters. Glutathione has been shown
to play a major role in the antioxidant defense system
and its deficiency increases the levels of oxidative stress,
which could lead to the pathogenesis of many diseases
including heart related diseases [48]. The protective role
of GSHPx and SOD against hydrogen peroxide radicals
and superoxide anions, respectively, has been studied.
In hypercholesterolemic conditions, both GSHPx and
SOD activities were decreased [8,9,49,50]. Therefore, in-
creased antioxidants indicate the protection against oxida-
tive stress.
In our study, both fish oil and spirulina inhibited lipid
peroxidation and restored the antioxidant status in ham-
sters. While there was no significant change in hepatic
GSH level in the post FO and post SP groups, there were
significant increases in hepatic GSH level, GSHPx and
SOD activities in the post SF group. According to the
findings of Grotto et al. [22], the effect of fish oil on oxi-
dative stress was not related to its antioxidant ability.
Though this study assessed the antioxidant status, the
oxidation process was not as a result of hypercholester-
olemia. Another study showed that fish oil possessed
antioxidant properties, and hypercholesterolemia was
not a factor either [19]. The previous findings were con-
sistent with our finding that fish oil increased the activity
of antioxidant enzymes when hypercholesterolemia was as
a factor [23,24]. Spirulina also increased the activity of
antioxidant enzymes. The previous studies have shown
that spirulina had antioxidant properties [35,37,51]. These
findings suggest that both fish oil and spirulina can pre-
vent oxidative stress and further improve the antioxidant
status. In addition, only the post SF group but not the pre-
SF and HF + SF groups inhibited lipid peroxidation and re-
stored the antioxidant status to above or to control levels,
which indicates that a combination of spirulina and fish
oil is beneficial only when factors causing oxidative stress
are eliminated.
Inflammation and hypercholesterolemia have been linked
to the pathogenesis of cardiovascular disease. Consequently,
cytokines have been shown to play an important role inthe pathogenesis of cardiovascular disease and hence they
become an important target for therapy [52,53]. While the
role of TNF-α and IL-1β in the pathogenesis of athero-
sclerosis is linked to the recruitment of macrophages and
the accumulation of cholesterol in the arterial wall [54,55],
IL-10 works as an anti-inflammatory cytokine which in-
hibits inflammation and limits adverse outcomes in car-
diovascular disease [56]. In our study, a high cholesterol
diet increased inflammation by increasing TNF-α and IL-
1β and reducing the anti-inflammatory cytokine IL-10.
Furthermore, single treatment of fish oil or spirulina
regulated inflammation by decreasing the concentra-
tion of TNF-α and IL-1β and increasing the concen-
tration of IL-10. However, there were differential results
that were observed when spirulina and fish oil were
combined. The pre-SF and HF + SF groups increased
TNF-α concentration, while the post-SF and pre-SF
groups increased anti-inflammatory cytokine IL-10. The
previous studies supported that fish oil modulated
inflammatory cytokines by inhibiting the activation of
transcription factor nuclear factor-κB [57,58]. Spirulina
exhibited its ability in inhibiting inflammation. The anti-
inflammatory effect of spirulina may be attributed to
c-phycocyanin, a selective inhibitor of cyclooxygenase-2
[59,60].
The limit of this study is that the experimental diet
was not maintained a high cholesterol diet for entire
8 weeks in all the treatment groups, therefore, the com-
parison between the treatment groups and the HF group
was only performed between the HF + SF and HF groups
which were given a high cholesterol diet for 8 weeks.
Whereas other treatment groups were fed combined high
cholesterol and control diets, and each diet was given for
4 weeks, the comparisons were made among the pre- and
post-treatment groups rather than the HF group. The
study for determining the effects of the treatments in the
animals given a high cholesterol diet can be further con-
ducted in the future. In addition, the results of this study
can be applied to future human study. Human equivalent
doses of fish oil and spirulina translated from hamsters
are 1.0 and 0.1 mg/kg body weight, respectively, using the
body surface area normalization method and the conver-
sion Km factor of 0.135 from 0.08-kg hamsters to 60-kg
adults [61].
Conclusions
Consumption of a high cholesterol diet ad libitum pos-
sesses detrimental effects on plasma lipids, oxidative stress,
and inflammation. Single treatments of fish oil (post FO)
and spirulina (post SP) possess protective effects against
oxidative stress and inflammation. This effect was also
observed when a combination of fish oil and spirulina
(post SF) was administered after inducing hypercholes-
terolemia, unlike when the combination was given before
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Spirulina (post SP) exhibited decreased TC level, LDL-C
level, TC:HDL ratio, and atherogenic index of plasma, and
increased HDL-C level compared with fish oil (post FO)
and combined fish oil and spirulina (post SF) groups. Our
findings suggest that the use of spirulina could decrease
high cholesterol levels, while fish oil could worsen the
lipid levels. In addition, both fish oil and spirulina and
their combination (post SF) may be effective in improving
oxidative stress and inflammation in hamsters fed a high
cholesterol diet.
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